drugset / Trial / NCT00397826

Evaluation of the Effects of Simvastatin 40mg

NCT00397826

Phase 4 Completed 20 enrolled Cardinal Tien Hospital
NaSingle-groupOpen-labelTreatment

Summary

To collect lipid-lowering response data with the use of simvastatin 40 mg tablet in patients with hypercholesterolemia.

Timeline

Start
2005-01
Primary completion
2006-01
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule 40 mg

Indications